Genetic screening for newborns after a serious pregnancy loss
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This trial looks at doing early genetic testing in newborns/early life cases after a serious pregnancy loss, to learn whether genetics can help understand why it happened. If you have the right timing and sample availability, the results may help future “more precise” care planning and research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The baby is less than 100 days old
- The pregnancy loss happened after 20 weeks and the baby weighed more than 500 grams
- A biological sample (like blood or tissue) is available that can be used for DNA genetic testing
- A parent or legal guardian can give informed consent
- You must be willing to use genetic test data for future research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects genetic information from very young newborns to better understand early-life health. Your child’s information may help researchers learn about genetics and future research.
This trial uses genetic testing to better understand the cause of a newborn’s birth defect and to help doctors choose more personalized treatment. It may help families get clearer answers and more targeted care.
This study looks at using whole genome sequencing in newborns and families with ongoing pregnancies, including those conceived naturally or with fertility treatments. It aims to better understand and manage genetic disease risks early.
This study uses advanced genetic testing (whole genome sequencing) on tissue samples from fetuses with structural abnormalities detected on ultrasound. The goal is to identify genetic causes of birth defects to help with diagnosis and understanding of your baby's condition.
This study examines genetic material from miscarriages to understand why early pregnancy loss happens. Researchers analyze a blood sample taken right after miscarriage to look for clues that might help explain what went wrong and potentially prevent future losses.
This research study tests a new way to screen newborns for hundreds of genetic diseases using a sample of their blood or saliva. It aims to find conditions early so your baby can get the right care sooner.
Hear when a new Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.